Profile
Full Name
Agios Pharmaceuticals, Inc.Ticker Symbol
AGIOExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
July 24, 2013Indexes
Not includedWebsite
http://www.agios.comEmployees
486Key Details
Price
$28.97
Market Cap
$1.66B(Small cap)
Last Dividend
-
TTM Dividend Yield
-
Annual Revenue
$36.50M(+36.07% YoY)
Annual EPS
$11.64(+283.89% YoY)
PE Ratio
2.55
Next earnings date
May 2, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Agios Pharmaceuticals doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Feb 24, 25 HC Wainwright & Co.
BuyDec 18, 24 Cantor Fitzgerald
OverweightDec 10, 24 RBC Capital
OutperformDec 9, 24 Scotiabank
Sector OutperformNov 1, 24 Scotiabank
Sector OutperformOct 16, 24 Scotiabank
Sector OutperformSep 27, 24 Leerink Partners
Market PerformSep 20, 24 Cantor Fitzgerald
OverweightSep 19, 24 RBC Capital
OutperformAug 2, 24 RBC Capital
OutperformInstitutional Ownership
- What is the ticker symbol for Agios Pharmaceuticals?
- Does Agios Pharmaceuticals pay dividends?
- What sector is Agios Pharmaceuticals in?
- What industry is Agios Pharmaceuticals in?
- What country is Agios Pharmaceuticals based in?
- When did Agios Pharmaceuticals go public?
- Is Agios Pharmaceuticals in the S&P 500?
- Is Agios Pharmaceuticals in the NASDAQ 100?
- Is Agios Pharmaceuticals in the Dow Jones?
- When was Agios Pharmaceuticals's last earnings report?
- When does Agios Pharmaceuticals report earnings?
- Should I buy Agios Pharmaceuticals stock now?
What is the ticker symbol for Agios Pharmaceuticals?
The ticker symbol for Agios Pharmaceuticals is NASDAQ:AGIO
Does Agios Pharmaceuticals pay dividends?
No, Agios Pharmaceuticals does not pay dividends
What sector is Agios Pharmaceuticals in?
Agios Pharmaceuticals is in the Healthcare sector
What industry is Agios Pharmaceuticals in?
Agios Pharmaceuticals is in the Biotechnology industry
What country is Agios Pharmaceuticals based in?
Agios Pharmaceuticals is headquartered in United States
When did Agios Pharmaceuticals go public?
Agios Pharmaceuticals's initial public offering (IPO) was on July 24, 2013
Is Agios Pharmaceuticals in the S&P 500?
No, Agios Pharmaceuticals is not included in the S&P 500 index
Is Agios Pharmaceuticals in the NASDAQ 100?
No, Agios Pharmaceuticals is not included in the NASDAQ 100 index
Is Agios Pharmaceuticals in the Dow Jones?
No, Agios Pharmaceuticals is not included in the Dow Jones index
When was Agios Pharmaceuticals's last earnings report?
Agios Pharmaceuticals's most recent earnings report was on Feb 13, 2025
When does Agios Pharmaceuticals report earnings?
The next expected earnings date for Agios Pharmaceuticals is May 2, 2025
Should I buy Agios Pharmaceuticals stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions